GlassScriptPhysician profile
Jaslin Kaur
NPI 1699414359
$1,003.36
in general payments reported to CMS, 2019-2025
10 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.60 · 2023: $318 · 2024: $182 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.65 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $191.59 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $119.77 | 2022-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $112.54 | 2023-2025 | |
| Esperion Therapeutics, INC. | $70.17 | 2024-2025 | Nexletol |
| Amgen INC. | $55.13 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.75 | 2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $22.71 | 2023 | Assure Wcd |
| Lilly USA, LLC | $22.54 | 2025 | Zepbound |
| Lexicon Pharmaceuticals, INC. | $19.51 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaslin Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.